Erratum: GLRB is the third major gene of effect in hyperekplexia (Human Molecular Genetics (2013) 22 (927–940) DOI: 10.1093/hmg/dds498);GLRB is the third major gene of effect in hyperekplexia

Human Molecular Genetics

Volumn 22, Issue 5, 2013, Pages 927-940

  Chung, Seo Kyung ^a   Bode, Anna ^b   Cushion, Thomas D ^a   Thomas, Rhys H ^a   Hunt, Charlotte ^a   Wood, Sian Elin ^a   Pickrell, William O ^a   Drew, Cheney J G ^a   Yamashita, Sumimasa ^c   Shiang, Rita ^d   Leiz, Steffen ^e   Longhardt, Ann Carolyn ^f   Raile, Vera ^f   Weschke, Bernhard ^f   Puri, Ratna D ^g   Verma, Ishwar C ^g   Harvey, Robert J ^h   Ratnasinghe, Didi D ⁱ   Parker, Michael ^j   Rittey, Chris ^j   Masri, Amira ^k   Lingappa, Lokesh ^l   Howell, Owain W ^a   Vanbellinghen, Jean François ^m   Mullins, Jonathan G ^a   Lynch, Joseph W ^b   Rees, Mark I ^a   more..

^a SWANSEA UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Klinikum Dritter Orden   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g SIR GANGA RAM HOSPITAL   (India)

^h UNIVERSITY OF LONDON   (United Kingdom)

ⁱ WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^j SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^k THE UNIVERSITY OF JORDAN   (Jordan)

^l Rainbow Children's Hospital   (India)

^m Institut de Pathologie and Genetique   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; GENOMIC DNA; GLYCINE RECEPTOR; GLYCINE RECEPTOR BETA SUBUNIT; GLYCINE TRANSPORTER 2; UNCLASSIFIED DRUG;

ADULT; APNEA ATTACK; APRAXIA; ARTICLE; BIOTINYLATION; BRAIN STEM; CHILD; CLONIC SEIZURE; CONVERGENT STRABISMUS; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; FALLING; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HICCUP; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYDROGEN BOND; HYPEREKPLEXIA; INDEL MUTATION; INFANT; LEARNING DISORDER; MAJOR CLINICAL STUDY; MAJOR GENE; MISSENSE MUTATION; MOLECULAR MODEL; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MULTIPLEX POLYMERASE CHAIN REACTION; MUSCLE HYPERTONIA; NEUROTRANSMISSION; NEWBORN APNEA; NONSENSE MUTATION; NULL ALLELE; PATHOGENICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL CORD; SPLICING DEFECT; STARTLE REFLEX; STOP CODON; TACTILE STIMULATION;

EID: 84873416725     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt147     Document Type: Erratum

References (48)

1. Shiang, R., Ryan, S.G., Zhu, Y.Z., Hahn, A.F., O'Connell, P. and Wasmuth, J.J. (1993) Mutations in the alpha 1 subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nat. Genet., 5, 351-358.
2. Rees, M.I., Harvey, K., Pearce, B.R., Chung, S.K., Duguid, I.C., Thomas, P., Beatty, S., Graham, G.E., Armstrong, L., Shiang, R. et al. (2006) Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease. Nat. Genet., 38, 801-806.
3. Harvey, R.J., Topf, M., Harvey, K. and Rees, M.I. (2008) The genetics of hyperekplexia: more than startle! Trends Genet., 24, 439-447.
4. Chung, S.K., Vanbellinghen, J.F., Mullins, J.G., Robinson, A., Hantke, J., Hammond, C.L., Gilbert, D.F., Freilinger, M., Ryan, M., Kruer, M.C. et al. (2010) Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexia. J. Neurosci., 30, 9612-9620.
5. Thomas, R.H., Hammond, C.L., Bodger, O.G., Rees, M.I. and Smith, P.E. (2010) Identifying and prioritising epilepsy treatment uncertainties. J. Neurol. Neurosurg. Psychiatry, 81, 918-921.
6. Rees, M.I., Andrew, M., Jawad, S. and Owen, M.J. (1994) Evidence for recessive as well as dominant forms of startle disease (hyperekplexia) caused by mutations in the alpha 1 subunit of the inhibitory glycine receptor. Hum. Mol. Genet., 3, 2175-2179.
7. Rees, M.I., Lewis, T.M., Vafa, B., Ferrie, C., Corry, P., Muntoni, F., Jungbluth, H., Stephenson, J.B., Kerr, M., Snell, R.G. et al. (2001) Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. Hum. Genet., 109, 267-270.
8. Grudzinska, J., Schemm, R., Haeger, S., Nicke, A., Schmalzing, G., Betz, H. and Laube, B. (2005) The beta subunit determines the ligand binding properties of synaptic glycine receptors. Neuron, 45, 727-739.
9. Yang, Z., Taran, E., Webb, T.I. and Lynch, J.W. (2012) Stoichiometry and subunit arrangement of alpha1beta glycine receptors as determined by atomic force microscopy. Biochemistry, 51, 5229-5231.
10. Meyer, G., Kirsch, J., Betz, H. and Langosch, D. (1995) Identification of a gephyrin binding motif on the glycine receptor beta subunit. Neuron, 15, 563-572.
11. Fritschy, J.M., Harvey, R.J. and Schwarz, G. (2008) Gephyrin: where do we stand, where do we go? Trends Neurosci., 31, 257-264.
12. Herweg, J. and Schwarz, G. (2012) Splice-specific glycine receptor binding, folding, and phosphorylation of the scaffolding protein gephyrin. J. Biol. Chem., 287, 12645-12656.
13. Carta, E., Chung, S.K., James, V.M., Robinson, A., Gill, J.L., Remy, N., Vanbellinghen, J.F., Drew, C.J., Cagdas, S., Cameron, D. et al. (2012) Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J. Biol. Chem., 287, 28975-28985.
14. Rees, M.I., Lewis, T.M., Kwok, J.B., Mortier, G.R., Govaert, P., Snell, R.G., Schofield, P.R. and Owen, M.J. (2002) Hyperekplexia associated with compound heterozygote mutations in the beta-subunit of the human inhibitory glycine receptor (GLRB). Hum. Mol. Genet., 11, 853-860.
15. Shan, Q., Han, L. and Lynch, J.W. (2011) Beta subunit M2-M3 loop conformational changes are uncoupled from alpha1 beta glycine receptor channel gating: implications for human hereditary hyperekplexia. PLoS One, 6, e28105.
16. Kingsmore, S.F., Giros, B., Suh, D., Bieniarz, M., Caron, M.G. and Seldin, M.F. (1994) Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat. Genet., 7, 136-141.
17. Mulhardt, C., Fischer, M., Gass, P., Simon-Chazottes, D., Guenet, J.L., Kuhse, J., Betz, H. and Becker, C.M. (1994) The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of L1 element. Neuron, 13, 1003-1015.
18. Hirata, H., Saint-Amant, L., Downes, G.B., Cui, W.W., Zhou, W., Granato, M. and Kuwada, J.Y. (2005) Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit. Proc. Natl. Acad. Sci. USA, 102, 8345-8350.
19. Lee, C.G., Kwon, M.J., Yu, H.J., Nam, S.H., Lee, J., Ki, C.S. and Lee, M. (2012) Clinical features and genetic analysis of children with hyperekplexia in Korea. J. Child Neurol., [epub ahead of print].
20. Al-Owain, M., Colak, D., Al-Bakheet, A., Al-Hashmi, N., Shuaib, T., Al-Hemidan, A., Aldhalaan, H., Rahbeeni, Z., Al-Sayed, M., Al-Younes, B. et al. (2012) Novel mutation in GLRB in a large family with hereditary hyperekplexia. Clin. Genet., 81, 479-484.
21. Harvey, K., Duguid, I.C., Alldred, M.J., Beatty, S.E., Ward, H., Keep, N.H., Lingenfelter, S.E., Pearce, B.R., Lundgren, J., Owen, M.J. et al. (2004) The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J. Neurosci., 24, 5816-5826.
22. Rees, M.I., Harvey, K., Ward, H., White, J.H., Evans, L., Duguid, I.C., Hsu, C.C., Coleman, S.L., Miller, J., Baer, K. et al. (2003) Isoform heterogeneity of the human gephyrin gene (GPHN), binding domains to the glycine receptor, and mutation analysis in hyperekplexia. J. Biol. Chem., 278, 24688-24696.
23. Kalscheuer, V.M., Musante, L., Fang, C., Hoffmann, K., Fuchs, C., Carta, E., Deas, E., Venkateswarlu, K., Menzel, C., Ullmann, R. et al. (2009) A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum. Mutat., 30, 61-68.
24. Lesca, G., Till, M., Labalme, A., Vallee, D., Hugonenq, C., Philip, N., Edery, P. and Sanlaville, D. (2011) De novo Xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features. Am. J. Med. Genet. A, 155A, 1706-1711.
25. Marco, E.J., Abidi, F.E., Bristow, J., Dean, W.B., Cotter, P., Jeremy, R.J., Schwartz, C.E. and Sherr, E.H. (2008) ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal. J. Med. Genet., 45, 100-105.
26. Shimojima, K., Sugawara, M., Shichiji, M., Mukaida, S., Takayama, R., Imai, K. and Yamamoto, T. (2011) Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. J. Hum. Genet., 56, 561-565.
27. Eguchi, M., Eguchi-Ishimae, M. and Greaves, M. (2004) The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood, 103, 3876-3882.
28. Eguchi, M., Eguchi-Ishimae, M., Seto, M., Morishita, K., Suzuki, K., Ueda, R., Ueda, K., Kamada, N. and Greaves, M. (2001) GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24). Genes Chromosomes Cancer, 32, 212-221.
29. Kuwada, N., Kimura, F., Matsumura, T., Yamashita, T., Nakamura, Y., Wakimoto, N., Ikeda, T., Sato, K. and Motoyoshi, K. (2001) T(11;14)(q23;q24) generates an MLL-human gephyrin fusion gene along with a de facto truncated MLL in acute monoblastic leukemia. Cancer Res., 61, 2665-2669.
30. Reiss, J. and Hahnewald, R. (2011) Molybdenum cofactor deficiency: mutations in GPHN, MOCS1, and MOCS2. Hum. Mutat., 32, 10-18.
31. Reiss, J., Lenz, U., Aquaviva-Bourdain, C., Joriot-Chekaf, S., Mention-Mulliez, K. and Holder-Espinasse, M. (2011) A GPHN point mutation leading to molybdenum cofactor deficiency. Clin. Genet., 80, 598-599.
32. Macaya, A., Brunso, L., Fernandez-Castillo, N., Arranz, J.A., Ginjaar, H.B., Cuenca-Leon, E., Corominas, R., Roig, M. and Cormand, B. (2005) Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: a clinical, biochemical and genetic study. Neuropediatrics, 36, 389-394.
33. Reiss, J., Gross-Hardt, S., Christensen, E., Schmidt, P., Mendel, R.R. and Schwarz, G. (2001) A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am. J. Hum. Genet., 68, 208-213.
34. Becker, K., Hohoff, C., Schmitt, B., Christen, H.J., Neubauer, B.A., Sandrieser, T. and Becker, C.M. (2006) Identification of the microdeletion breakpoint in a GLRA1null allele of Turkish hyperekplexia patients. Hum. Mutat., 27, 1061-1062.
35. Kruger, W., Gilbert, D., Hawthorne, R., Hryciw, D.H., Frings, S., Poronnik, P. and Lynch, J.W. (2005) A yellow fluorescent protein-based assay for high-throughput screening of glycine and GABAA receptor chloride channels. Neurosci. Lett., 380, 340-345.
36. Islam, R. and Lynch, J.W. (2012) Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels. Br. J. Pharmacol., 165, 2707-2720.
37. Mullins, J.G., Chung, S.K. and Rees, M.I. (2010) Fine architecture and mutation mapping of human brain inhibitory system ligand gated ion channels by high-throughput homology modeling. Adv. Protein Chem. Struct. Biol., 80, 117-152.
38. Hibbs, R.E. and Gouaux, E. (2011) Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature, 474, 54-60.
39. Chalphin, A.V. and Saha, M.S. (2010) The specification of glycinergic neurons and the role of glycinergic transmission in development. Front. Mol. Neurosci., 3, 11.
40. Betz, H. and Laube, B. (2006) Glycine receptors: recent insights into their structural organization and functional diversity. J. Neurochem., 97, 1600-1610.
41. Kirsch, J. and Betz, H. (1998) Glycine-receptor activation is required for receptor clustering in spinal neurons. Nature, 392, 717-720.
42. Baer, K., Waldvogel, H.J., During, M.J., Snell, R.G., Faull, R.L. and Rees, M.I. (2003) Association of gephyrin and glycine receptors in the human brainstem and spinal cord: an immunohistochemical analysis. Neuroscience, 122, 773-784.
43. Waldvogel, H.J., Baer, K., Allen, K.L., Rees, M.I. and Faull, R.L. (2007) Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study. J. Comp. Neurol., 502, 1012-1029.
44. Brackmann, M., Zhao, C., Schmieden, V. and Braunewell, K.H. (2004) Cellular and subcellular localization of the inhibitory glycine receptor in hippocampal neurons. Biochem. Biophys. Res. Commun., 324, 1137-1142.
45. Sibilla, S. and Ballerini, L. (2009) GABAergic and glycinergic interneuron expression during spinal cord development: dynamic interplay between inhibition and excitation in the control of ventral network outputs. Prog. Neurobiol., 89, 46-60.
46. Molon, A., Di Giovanni, S., Hathout, Y., Natale, J. and Hoffman, E.P. (2006) Functional recovery of glycine receptors in spastic murine model of startle disease. Neurobiol. Dis., 21, 291-304.
47. Davies, J.S., Chung, S.K., Thomas, R.H., Robinson, A., Hammond, C.L., Mullins, J.G., Carta, E., Pearce, B.R., Harvey, K., Harvey, R.J. et al. (2010) The glycinergic system in human startle disease: a genetic screening approach. Front. Mol. Neurosci., 3, 1-8.
48. Lape, R., Plested, A.J., Moroni, M., Colquhoun, D. and Sivilotti, L.G. (2012) The alpha1K276E startle disease mutation reveals multiple intermediate states in the gating of glycine receptors. J. Neurosci., 32, 1336-1352.